Cargando…
Cyclo (MQCNS) has the potential to treat ischemic stroke
We previously found that monocyte locomotion inhibitory factor has a neuroprotective effect on ischemic brain injury during the acute phase of stroke. Therefore, we modified the structure of an anti-inflammatory monocyte locomotion inhibitory factor peptide to construct an active cyclic peptide—Cycl...
Autores principales: | Song, Zhibing, Li, Xinyu, Lv, Mengting, Guo, Yuchen, Deng, Shanshan, Zhang, Yuefan, Li, Tiejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360098/ https://www.ncbi.nlm.nih.gov/pubmed/37282473 http://dx.doi.org/10.4103/1673-5374.371367 |
Ejemplares similares
-
Network pharmacology and molecular docking-based analysis of protective mechanism of MLIF in ischemic stroke
por: Lv, Mengting, et al.
Publicado: (2022) -
MLIF Modulates Microglia Polarization in Ischemic Stroke by Targeting eEF1A1
por: Liu, Yulan, et al.
Publicado: (2021) -
Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway
por: Zhang, Qian, et al.
Publicado: (2021) -
Tanshinone IIA Protects Against Cerebral Ischemia Reperfusion Injury by Regulating Microglial Activation and Polarization via NF-κB Pathway
por: Song, Zhibing, et al.
Publicado: (2021) -
Editorial: The Potential Effect and Mechanism of Traditional Medicine on Vascular Homeostasis and Remodeling: An Update
por: Zhang, Yuefan, et al.
Publicado: (2022)